Generally underwhelming Q2FY25 results pushed the earnings per share (EPS) downgrade-to-upgrade ratio to 2.14, dampening market sentiment.
The company's operating profit margin slipped by 80 basis points on a sequential basis to 8.8 per cent and was lower than street expectations
Management credits demand-supply gap, shifting demographics for hitting the 'suite spot'
PVC resin saw a 19 per cent rise during the June quarter, which was followed by a 17 per cent fall in July and August
Ram Prasad Sahu lists top picks by brokerages for Samvat 2081
Brokerages slash target price after subdued Q2 show
Home stretch for real estate investment trusts as strength of the office leasing market and Q2 results show endurance
Weak Q2 show that led to recent weakness in stock price likely to weigh on near-term outlook
Margin constraints could trip up earnings performance
Stock slumps over 13% on weak Q2 results, subdued festive demand outlook
Competitive pressures add to logistics firm's demand woes
The carmaker's short-term gains may stall in neutral over high valuations
Apart from trading at a discount to their historic valuation, many companies are industry leaders with superior balance sheets and financial ratios
Coming soon: Blockbuster content pipeline and asset-light model promise a box-office hit for investors
Near-term demand is lower amidst a host of factors such as inflationary challenges on consumer spending, rural weakness, and Q2 being a seasonally weak quarter post a strong summer
Acquisitions, organic growth to improve profit trajectory
Most brokerages believe that the content pipeline in the December quarter will help the company surpass the performance in Q2FY24
Pricing pulse check: US market demand, domestic stability as growth tonics
While the brokerage is watchful of global growth slowing down, it expects inorganic growth to aid in the outperformance of Samvardhana Motherson
Going ahead, the Street will track the sales and margin trajectory. Sales growth in the quarter came in ahead of estimates in a seasonally weak quarter due to lower sales of Vicks